Replies to post #1844 on Antares Pharma, Inc. (ATRS)

[Bio_pete]

When ATRS first discussed the PFE deal management stated that we would learn the identity when the Phase III started. I think they referenced the Clinicaltrials.gov website & I understood it to mean they would be free to let us know the drug. I'm going to try & find the earning call transcript with the exact wording.

[jab91252]

So today for grins and giggles, I followed up and called the Pfizer 1 800 call center number. Its a recording and you leave your name, phone number, email, the study your calling about, etc. So in my message I said I was interested in Study ID B3491010? for the Chicago area, thinking because I live in the 'far' suburban of about 25 miles from downtown Chitown and listed the city previously that I was excluded because I was maybe too far and this would help answer that question. The reply today was:

"Unfortunately, the study you are interested in is not being conducted in your area. Please keep checking the website. If you find a trial you are interested in that becomes available in or near Chicago, please call the Pfizer ClinicalTrials.gov call center at 1-800-718-1021."

So, I'm thinking that maybe the enrollment must not be all that large since they are not including an area like the Chicago area. Or, the areas that will be included have enough of us "weekend warriors" to capture whatever enrollment is required.

ATRS held up quite well today given the beating the market took! Where were all the ATRS shorts the past two days??? One would think we would see more downside like most other stocks. There's resilience being demonstrated and I view that as a plus going forward!